4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-063930
Director sold 6,000 shares at an average $58.84 ($353,040)
- Director acquired 6,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…